Andrew D. Dickinson - 06 Feb 2022 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role
Chief Financial Officer
Signature
/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
06 Feb 2022
Net transactions value
-$49,011
Form type
4
Filing time
08 Feb 2022, 19:25:56 UTC
Previous filing
28 Jan 2022
Next filing
13 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise $0 +1,817 +3.1% $0.000000 60,473 06 Feb 2022 Direct F1
transaction GILD Common Stock Tax liability $49,011 -767 -1.3% $63.90 59,706 06 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -1,817 -4.9% 35,560 06 Feb 2022 Common Stock 1,817 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.